Dr. med. Armin Atzinger

Department of Nuclear Medicine

Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging (2022) Schmidkonz C, Kuwert T, Atzinger A, Cordes M, Schett G, Ramming A, Götz T Journal article, Review article Fibroblast Activation in Psoriasis Patients Assessed by Ga-68-FAPI-04 PET-CT Is Associated with Progression to Psoriatic Arthritis (2022) Fagni F, Simon D, Kleyer A, Tascilar K, Taubmann J, Bayat S, Minopoulou I, et al. Conference contribution Fibroblast Activation Protein (FAP) PET-CT for Depicting Inflammatory Joint Damage in Patients with Psoriatic Arthritis (2022) Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Raimondo MG, Labinsky H, Treutlein C, et al. Conference contribution Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naive patients with non-small cell lung cancer (2022) Zhang R, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, Schmidkonz C, Atzinger A, Kuwert T, et al. Journal article FIBROBLAST ACTIVATION PROTEIN (FAP) PET-CT IMAGING ALLOWS TO DEPICT INFLAMMATORY JOINT REMODELING IN PATIENTS WITH PSORIATIC ARTHRITIS (2022) Schmidkonz C, Rauber S, Raimondo MG, Labinsky H, Atzinger A, Treutlein C, Knitza J, et al. Conference contribution Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging (2021) Schmidkonz C, Rauber S, Atzinger A, Götz TI, Soare A, Cordes M, Prante O, et al. Journal article Ga-68-FAPI-04 PET/CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-related interstitial lung disease (2021) Schmidkonz C, Distler J, Treutlein C, Atzinger A, Prante O, Ritt P, Goetz T, et al. Journal article 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Conference contribution 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Journal article Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging (2020) Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Götz TI, Soare A, Cordes M, et al. Journal article